(PROK) ProKidney - Performance -72.4% in 12m
Compare PROK with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-76.62%
#123 in Group
Rel. Strength
7.10%
#7392 in Universe
Total Return 12m
-72.36%
#132 in Group
Total Return 5y
-92.86%
#123 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -8.68%
(?) Percentile in Group
12m Total Return: PROK (-72.4%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: PROK vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for PROK
| Total Return (including Dividends) | PROK | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 23.85% | 2.02% | 2.87% |
| 3 Months | -54.63% | -15.44% | -6.42% |
| 12 Months | -72.36% | -14.02% | 9.87% |
| 5 Years | -92.86% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | PROK | XBI | S&P 500 |
| 1 Month | -1.80% | 57% | 89.4% |
| 3 Months | -80.2% | -82.3% | -72% |
| 12 Months | -93.5% | -53.1% | 49.3% |
| 5 Years | -71.5% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #151 | 21.4% | 20.4% |
| 3 Month | #189 | -46.4% | -51.5% |
| 12 Month | #132 | -67.9% | -74.8% |
| 5 Years | #116 | -87.4% | -94.9% |
FAQs
Does PROK ProKidney outperforms the market?
No,
over the last 12 months PROK made -72.36%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months PROK made -54.63%, while XBI made -15.44%.
Over the last 3 months PROK made -54.63%, while XBI made -15.44%.
Performance Comparison PROK vs Indeces and Sectors
PROK vs. Indices PROK is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -8.16% | 21.0% | -61.3% | -82.2% |
| US NASDAQ 100 | QQQ | -8.41% | 19.1% | -61.7% | -83.7% |
| US Dow Jones Industrial 30 | DIA | -8.44% | 22.2% | -60.3% | -78.7% |
| German DAX 40 | DAX | -10.3% | 4.57% | -86.9% | -97.4% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -8.82% | 17.6% | -60.5% | -78.0% |
| Hongkong Hang Seng | HSI | -11.7% | 7.64% | -70.8% | -84.5% |
| India NIFTY 50 | INDA | -5.77% | 21.6% | -63.2% | -74.7% |
| Brasil Bovespa | EWZ | -10.2% | 12.3% | -70.5% | -65.9% |
PROK vs. Sectors PROK is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -8.34% | 20.2% | -67.5% | -92.7% |
| Consumer Discretionary | XLY | -9.08% | 20.3% | -59.1% | -86.4% |
| Consumer Staples | XLP | -7.79% | 21.8% | -68.2% | -79.9% |
| Energy | XLE | -9.14% | 23.8% | -55.3% | -62.6% |
| Financial | XLF | -8.79% | 18.3% | -67.2% | -93.9% |
| Health Care | XLV | -4.37% | 28.2% | -56.1% | -66.4% |
| Industrial | XLI | -9.73% | 16.5% | -62.3% | -82.4% |
| Materials | XLB | -8.15% | 19.1% | -57.3% | -66.3% |
| Real Estate | XLRE | -7.83% | 17.7% | -63.7% | -85.8% |
| Technology | XLK | -9.05% | 17.1% | -59.0% | -79.4% |
| Utilities | XLU | -9.20% | 18.2% | -69.1% | -88.3% |
| Aerospace & Defense | XAR | -8.67% | 14.5% | -70.6% | -97.5% |
| Biotech | XBI | -0.08% | 21.8% | -40.2% | -58.3% |
| Homebuilder | XHB | -7.72% | 20.8% | -47.7% | -62.6% |
| Retail | XRT | -8.31% | 20.3% | -55.0% | -68.0% |